| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |